TREM2 deletion enhances tau dispersion through pathogenic microglial exosomes. A tetravalent TREM2 agonist could reprogram microglial exosome cargo from tau-spreading vesicles to protective, tau-degrading vesicles while enhancing phagocytic clearance of extracellular tau.
Debate provenance: derived from debate `sess_SDA-2026-04-03-gap-tau-prop-20260402003221` on question: Investigate prion-like spreading of tau pathology through connected brain regions, focusing on trans-synaptic transfer, extr
Recombinant pro-cathepsin D enhances pathological protein degradation in lysosomes. Targeted delivery of stabilized cathepsin D or small molecule enhancers of cathepsin activity could boost lysosomal tau clearance capacity, preventing accumulation and subsequent membrane damage-mediated escape.
Debate provenance: derived from debate `sess_SDA-2026-04-03-gap-tau-prop-20260402003221` on question: Investigate prion-like spreading of tau pathology through connected brain regions, focusing on trans-
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
AgonistCtsd
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
4/11
dimensions won
TREM2 Agonist Therapy to Redirect Microg
3/11
dimensions won
Cathepsin D Enhancement for Tau Degradat
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.60
0.60
Evidence
0.55
0.55
Novelty
0.60
0.60
Feasibility
0.00
0.00
Impact
0.00
0.00
Druggability
0.00
0.00
Safety
0.00
0.00
Competition
0.00
0.00
Data
0.00
0.00
Reproducible
0.00
0.00
KG Connect
0.54
0.50
Score Breakdown
Dimension
TREM2 Agonist Therapy to Redir
Cathepsin D Enhancement for Ta
Mechanistic
0.600
0.600
Evidence
0.550
0.550
Novelty
0.600
0.600
Feasibility
0.000
0.000
Impact
0.000
0.000
Druggability
0.000
0.000
Safety
0.000
0.000
Competition
0.000
0.000
Data
0.000
0.000
Reproducible
0.000
0.000
KG Connect
0.540
0.500
Evidence
TREM2 Agonist Therapy to Redirect Microglial Exosome Content
No evidence citations yet
Cathepsin D Enhancement for Tau Degradation
No evidence citations yet
Debate Excerpts
TREM2 Agonist Therapy to Redirect Microglial Exoso
4 rounds · quality: 0.95
Persona-Theorist
Based on my comprehensive research of tau propagation mechanisms and therapeutic intervention points, I'll now generate 7 novel therapeutic hypotheses targeting different aspects of the tau spread pat...
Persona-Skeptic
## Critical Evaluation of Tau Propagation Therapeutic Hypotheses
Based on my analysis, I'll provide a rigorous critique of each hypothesis, identifying specific weaknesses and providing revised confi...
Persona-Domain Expert
# Practical Feasibility Assessment of Tau Propagation Therapeutic Hypotheses
Based on my analysis, I'll provide a comprehensive druggability assessment for the most promising hypotheses, focusing on ...
Persona-Synthesizer
```json
{
"ranked_hypotheses": [
{
"title": "P2RX7-Mediated Exosome Secretion Blockade",
"description": "P2RX7 is an ATP-gated channel that triggers pathogenic exosome secretion from...
Cathepsin D Enhancement for Tau Degradation
4 rounds · quality: 0.95
Persona-Theorist
Based on my comprehensive research of tau propagation mechanisms and therapeutic intervention points, I'll now generate 7 novel therapeutic hypotheses targeting different aspects of the tau spread pat...
Persona-Skeptic
## Critical Evaluation of Tau Propagation Therapeutic Hypotheses
Based on my analysis, I'll provide a rigorous critique of each hypothesis, identifying specific weaknesses and providing revised confi...
Persona-Domain Expert
# Practical Feasibility Assessment of Tau Propagation Therapeutic Hypotheses
Based on my analysis, I'll provide a comprehensive druggability assessment for the most promising hypotheses, focusing on ...
Persona-Synthesizer
```json
{
"ranked_hypotheses": [
{
"title": "P2RX7-Mediated Exosome Secretion Blockade",
"description": "P2RX7 is an ATP-gated channel that triggers pathogenic exosome secretion from...